Fenofibrate is a lipid-lowering medication indicated as monotherapy to treat primary hyperlipidemia, mixed dyslipidemia, and hypertriglyceridemia. While this medication has been around for many years, its formulation has continued to evolve. The different fenofibrate...
It is always controversial to come up with a top 5 list but we went for it. Below we have put together a list of the top 5 landmark trials in hyperlipidemia management. (NOTE: This is part of a bigger project that I am working on with Sarah Zahirudin, PharmD,...
In late 2018, ACC and AHA came out with an update to their cholesterol guidelines. The last update was from 2013 so PCSK-9 inhibitors hadn’t even been approved at that time. Very High Risk Patients – My Biggest Takeaway I always had a hard time knowing...
Study Materials For Pharmacists
Free 18 Page PDF On The Most Notable Drug Interactions!
